SoftBank Group Reports Profit Beat, Boosted by Intel Stake
The Japanese technology investment company's bottom line was boosted by a surge in the value of its stake in Intel.
Deal or No Deal, AstraZeneca Stock Is a Bargain
The logic of a pharma megamerger is questionable, but AstraZeneca's record isn't.
Siemens Shares Fall as Digital Industries Order Growth Misses Expectations













